We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCN
26
Waste Connections
WCN
$42.7B
$3.29M 0.39%
18,407
+7,041
+62% +$1.27M
VRSK icon
27
Verisk Analytics
VRSK
$27.1B
$3.27M 0.39%
12,206
+9,596
+368% +$2.6M
CASY icon
28
Casey's General Stores
CASY
$31.6B
$3.27M 0.39%
8,705
+7,308
+523% +$2.73M
TXRH icon
29
Texas Roadhouse
TXRH
$13.2B
$3.27M 0.39%
18,498
+10,181
+122% +$1.72M
DLTR icon
30
Dollar Tree
DLTR
$24.1B
$3.27M 0.39%
46,435
+41,931
+931% +$3.82M
UNP icon
31
Union Pacific
UNP
$178B
$3.17M 0.38%
12,844
+7,438
+138% +$1.8M
CRI icon
32
Carter's
CRI
$1.43B
$3.15M 0.38%
48,425
+40,840
+538% +$2.62M
CNM icon
33
Core & Main
CNM
$8.17B
$3.14M 0.38%
+70,750
New +$3.39M
AAP icon
34
Advance Auto Parts
AAP
$3.48B
$3.05M 0.37%
+78,329
New +$4.15M
ICE icon
35
Intercontinental Exchange
ICE
$84.1B
$3.05M 0.36%
18,978
+8,042
+74% +$1.24M
ESNT icon
36
Essent Group
ESNT
$6.12B
$3.04M 0.36%
47,302
+40,336
+579% +$2.47M
BLK icon
37
Blackrock
BLK
$165B
$3.04M 0.36%
3,201
+519
+19% +$449K
TMO icon
38
Thermo Fisher Scientific
TMO
$208B
$3.01M 0.36%
4,867
-247
-5% -$146K
LULU icon
39
lululemon athletica
LULU
$13.4B
$2.97M 0.36%
+10,949
New +$2.91M
APH icon
40
Amphenol
APH
$184B
$2.95M 0.35%
45,342
+19,092
+73% +$1.24M
MGM icon
41
MGM Resorts International
MGM
$11.8B
$2.95M 0.35%
+75,431
New +$2.98M
EL icon
42
Estee Lauder
EL
$30.1B
$2.93M 0.35%
29,407
+17,948
+157% +$1.7M
FLS icon
43
Flowserve
FLS
$9.29B
$2.93M 0.35%
+56,616
New +$2.73M
PCG icon
44
PG&E
PCG
$47.2B
$2.89M 0.35%
+146,219
New +$2.74M
CPA icon
45
Copa Holdings
CPA
$5.65B
$2.89M 0.35%
30,788
+18,380
+148% +$1.66M
T icon
46
AT&T
T
$167B
$2.87M 0.34%
+130,427
New +$2.6M
CMG icon
47
Chipotle Mexican Grill
CMG
$42.6B
$2.86M 0.34%
49,665
+35,093
+241% +$1.94M
AIZ icon
48
Assurant
AIZ
$13.7B
$2.85M 0.34%
+14,351
New +$2.62M
COKE icon
49
Coca-Cola Consolidated
COKE
$12.4B
$2.84M 0.34%
+21,590
New +$2.65M
BRZE icon
50
Braze
BRZE
$2.65B
$2.79M 0.33%
86,340
+44,666
+107% +$1.76M
1
2
3 4 5

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.